Table 2.
Summary of 95% confidence intervals and P values for the pharmacokinetic parameters of ziprasidone on day 1.
AUC(0,12 h) Ratio of geometric means (%) | Cmax Ratio of geometric means (%) | tmax | ||||
---|---|---|---|---|---|---|
Day 1 | 95% CI | P value | 95% CI | P value | 95% CI | P value |
Normal vs mildly impaired renal function | 54,101 | 0.0558 | 52,112 | 0.1622 | −2,1 | 0.7709 |
Normal vs moderately impaired renal function | 79,149 | 0.5848 | 78,169 | 0.4718 | −2,2 | 1.0 |
Normal vs severely impaired renal function | 67,126 | 0.5806 | 64,138 | 0.7394 | −2,1 | 0.8842 |
Mildly impaired vs moderately impaired renal function | 108,203 | 0.0163 | 102,222 | 0.0385 | −1,2 | 0.7709 |
Mildly impaired vs severely impaired renal function | 91,171 | 0.1633 | 84,181 | 0.2816 | −1,2 | 0.8842 |
Moderately impaired vs severely impaired renal function | 61,115 | 0.2752 | 56,120 | 0.2954 | −2,1 | 0.8842 |
CI = confidence interval.